INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 21 filers reported holding INFLARX NV in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,123 | +592.0% | 141,652 | +326.3% | 0.01% | +900.0% |
| Q1 2022 | $61,000 | -61.4% | 33,229 | 0.0% | 0.00% | -75.0% |
| Q4 2021 | $158,000 | -3.7% | 33,229 | -47.5% | 0.00% | -20.0% |
| Q3 2021 | $164,000 | -34.9% | 63,341 | -25.4% | 0.01% | -37.5% |
| Q2 2021 | $252,000 | -27.6% | 84,900 | -4.7% | 0.01% | -38.5% |
| Q1 2021 | $348,000 | +176.2% | 89,123 | +256.9% | 0.01% | +160.0% |
| Q4 2020 | $126,000 | +18.9% | 24,969 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $106,000 | -9.4% | 24,969 | -1.9% | 0.01% | -25.0% |
| Q2 2020 | $117,000 | -29.9% | 25,444 | -41.9% | 0.01% | -42.9% |
| Q1 2020 | $167,000 | -29.8% | 43,783 | -27.1% | 0.01% | -33.3% |
| Q4 2019 | $238,000 | -37.7% | 60,056 | -61.1% | 0.02% | -40.0% |
| Q3 2019 | $382,000 | +70.5% | 154,507 | +117.5% | 0.04% | +75.0% |
| Q2 2019 | $224,000 | – | 71,032 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,876,413 | $54,116,000 | 31.91% |
| RA Capital Management | 1,620,653 | $46,740,000 | 3.58% |
| Cormorant Asset Management, LP | 1,399,030 | $40,348,000 | 3.01% |
| EMORY UNIVERSITY | 90,761 | $2,618,000 | 1.87% |
| Redmile Group, LLC | 851,100 | $24,546,000 | 0.95% |
| Eventide Asset Management | 275,000 | $7,931,000 | 0.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,394,132 | $40,207,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,500 | $2,552,000 | 0.09% |
| Baker Brothers Advisors | 200,000 | $5,768,000 | 0.05% |
| Artal Group S.A. | 125,000 | $3,605,000 | 0.04% |